EML4-ALK Rearrangement as a Mechanism of Resistance to Osimertinib in Metastatic Lung Adenocarcinoma: A Case Report.
JTO Clin Res Rep
; 2(6): 100179, 2021 Jun.
Article
in En
| MEDLINE
| ID: mdl-34590027
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
JTO Clin Res Rep
Year:
2021
Document type:
Article